LONA

LeonaBio, Inc. NASDAQ Listed Sep 18, 2020

Healthcare ·Biotechnology ·US · leonabio.com

$9.86

After hrs $10.04 +0.00%

Mkt Cap $38.9M

52w Low $4.25 73.2% of range 52w High $11.91

50d MA $6.75 200d MA $6.75

P/E (TTM) -0.4x

EV/EBITDA 0.4x

P/B 1.4x

Debt/Equity 0.0x

ROE -380.0%

P/FCF -0.7x

RSI (14) —

ATR (14) —

Beta 2.23

50d MA $6.75

200d MA $6.75

Avg Volume 63.9K

LeonaBio, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. Its product pipeline includes ATH-1105 for the treatment of amyotrophic lateral sclerosis, which is in phase 1 clinical trial; ATH-1020 for the treatment of neurodegenerative diseases, which is phase 1 clinical trial, as well as early compounds which is in preclinical phase. The company was formerly known as Athira Pharma, Inc. and changed its name to LeonaBio, Inc. in January 2026. LeonaBio, Inc. was incorporated in 2011 and is headquartered in Bothell, Washington.

SIC Code

2836

CIK (SEC)

1620463

Phone

425 620 8501

18706 North Creek Parkway · Bothell, WA 98011 · US

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Mar 26, 2026	AMC	-1.35	-18.92	-1300.3%	9.68	-8.2%	-7.3%	-4.2%	+6.2%	+3.5%	+17.3%	—
Nov 6, 2025	AMC	-1.06	-1.68	-58.5%	4.01	-1.5%	-4.0%	+14.2%	+15.5%	+17.2%	+17.2%	—
Aug 7, 2025	AMC	-1.80	-1.80	+0.0%	3.70	+4.1%	+5.9%	+2.7%	+4.1%	+5.4%	+7.6%	—
May 9, 2025	AMC	-0.20	-0.23	-15.0%	2.54	+13.0%	+6.3%	+10.2%	+2.4%	+9.8%	+7.1%	—
Feb 27, 2025	AMC	-0.23	-0.39	-69.6%	4.23	-3.1%	-2.8%	-11.1%	-11.6%	-10.4%	-17.3%	—
Nov 7, 2024	AMC	-0.80	-0.75	+6.2%	7.50	-4.7%	-12.0%	-13.7%	+6.7%	-2.7%	-4.8%	—
Aug 1, 2024	AMC	-0.75	-0.70	+6.7%	32.50	-0.9%	-1.2%	-3.1%	-3.1%	-4.6%	-5.5%	—
May 15, 2024	AMC	-0.80	-0.69	+13.8%	22.10	+5.9%	+22.6%	+14.0%	+14.0%	+14.9%	+18.6%	—
Feb 22, 2024	AMC	-0.96	-0.71	+26.0%	39.30	+1.8%	+0.0%	-0.5%	+2.0%	+1.0%	-2.0%	—
Nov 9, 2023	AMC	-0.87	-0.87	+0.0%	13.90	+7.9%	+6.5%	+12.2%	+9.4%	+14.4%	+13.7%	—
Aug 10, 2023	AMC	-0.81	-0.78	+3.7%	30.30	-0.3%	-7.3%	-7.6%	-11.9%	-12.5%	-13.5%	—
May 11, 2023	AMC	-0.66	-0.73	-10.6%	29.50	+0.0%	+0.0%	-2.7%	-8.1%	-6.4%	-3.7%	—

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Feb 19	Mizuho	Upgrade	Neutral → Outperform	—	$4.76	$5.12	+7.6%	+16.2%	+16.8%	+21.8%	+24.8%	+22.1%
Aug 10	JMP Securities	Maintains	Outperform → Outperform	—	$28.80	$28.90	+0.3%	+5.2%	-2.4%	-2.8%	-7.3%	-8.0%
May 14	Mizuho	Maintains	Buy → Buy	—	—	—	—	—	—	—	—	—
Mar 29	BTIG	Maintains	Buy → Buy	—	$22.60	$22.80	+0.9%	+4.9%	+8.8%	+10.6%	+11.5%	+8.4%
Mar 24	JMP Securities	Maintains	Market Outperform → Outperform	—	$24.00	$23.60	-1.7%	+2.1%	-1.2%	-5.8%	-1.2%	+2.5%
Jul 7	Mizuho	Maintains	Buy → Buy	—	$33.90	$35.00	+3.2%	+9.4%	+10.9%	-1.8%	-2.9%	+0.3%
Jun 22	Jefferies	Downgrade	Buy → Hold	—	$84.50	$26.40	-68.8%	-66.3%	-67.5%	-67.6%	-66.3%	-67.0%
Jun 22	JMP Securities	Downgrade	Market Outperform → Market Perform	—	$84.50	$26.40	-68.8%	-66.3%	-67.5%	-67.6%	-66.3%	-67.0%
Jun 22	Stifel	Downgrade	Buy → Hold	—	$84.50	$26.40	-68.8%	-66.3%	-67.5%	-67.6%	-66.3%	-67.0%
May 10	BTIG	Maintains	Buy → Buy	—	$88.40	$93.30	+5.5%	+4.9%	-4.8%	-10.0%	-6.3%	-1.9%
Apr 21	Berenberg	Maintains	Buy → Buy	—	$116.30	$119.80	+3.0%	+1.3%	-1.6%	-2.0%	-5.3%	-9.5%
Dec 15	Goldman Sachs	Maintains	Neutral → Neutral	—	$134.10	$132.10	-1.5%	-3.2%	-11.0%	-8.4%	-10.1%	-7.3%

Data updated apr 25, 2026 7:40pm · Source: massive.com